Company press releases

Displaying 1 - 20 of 20 results
Released Company Title Industry Topic
24 Apr 2024
08:00 CEST 		PHARMING GROUP Pharming Group to report first quarter 2024 financial results on May 8 20103015 Pharmaceuticals Meetings / events
24 Apr 2024
07:00 CEST 		PHARMING GROUP Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards 20103015 Pharmaceuticals Other subject
19 Apr 2024
18:43 CEST 		PHARMING GROUP Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025 20103015 Pharmaceuticals Other financial transaction
18 Apr 2024
15:04 CEST 		PHARMING GROUP Pharming Group announces the placement of €100 million convertible bonds due 2029 20103015 Pharmaceuticals Other financial transaction
18 Apr 2024
08:00 CEST 		PHARMING GROUP Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 20103015 Pharmaceuticals Other financial transaction
08 Apr 2024
07:00 CEST 		PHARMING GROUP Pharming announces completion of enrollment in pediatric clinical trial of leniolisib 20103015 Pharmaceuticals Other subject
04 Apr 2024
08:30 CEST 		PHARMING GROUP Pharming Group announces the 2024 Annual General Meeting of Shareholders 20103015 Pharmaceuticals General meeting / Board Meeting
04 Apr 2024
07:00 CEST 		PHARMING GROUP Pharming Group announces the filing of its 2023 Annual Report and Form 20-F 20103015 Pharmaceuticals Commercial results
03 Apr 2024
08:00 CEST 		PHARMING GROUP Pharming Group to participate in April investor conferences 20103015 Pharmaceuticals Meetings / events
14 Mar 2024
07:00 CET 		PHARMING GROUP Pharming Group reports fourth quarter and full year 2023 financial results 20103015 Pharmaceuticals Commercial results
29 Feb 2024
08:00 CET 		PHARMING GROUP Pharming Group to report fourth quarter and full year 2023 financial results on March 14 20103015 Pharmaceuticals Meetings / events
08 Feb 2024
08:00 CET 		PHARMING GROUP Pharming Group to participate in February investor conferences 20103015 Pharmaceuticals Meetings / events
08 Jan 2024
07:00 CET 		PHARMING GROUP Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update 20103015 Pharmaceuticals Commercial results
13 Dec 2023
07:00 CET 		PHARMING GROUP Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs) 20103015 Pharmaceuticals Other subject
21 Nov 2023
07:00 CET 		PHARMING GROUP Pharming announces first patient dosed in pediatric clinical trial for children aged 1 to 6 years for leniolisib 20103015 Pharmaceuticals Other subject
10 Nov 2023
14:51 CET 		PHARMING GROUP Pharming Group provides updates on EMA regulatory review of leniolisib MAA and plans to file for UK regulatory approval 20103015 Pharmaceuticals Other subject
01 Nov 2023
08:00 CET 		PHARMING GROUP Pharming Group to participate in November investor conferences 20103015 Pharmaceuticals -
26 Oct 2023
07:00 CEST 		PHARMING GROUP Pharming Group reports third quarter 2023 financial results 20103015 Pharmaceuticals Commercial results
12 Oct 2023
08:00 CEST 		PHARMING GROUP Pharming Group to report third quarter 2023 financial results on October 26 20103015 Pharmaceuticals Meetings / events
25 Sep 2023
16:00 CEST 		PHARMING GROUP Pharming Group reports on results of the 2023 Extraordinary General Meeting of Shareholders 20103015 Pharmaceuticals General meeting / Board Meeting